EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Association Between Prostate Volume and PI-RADS v2.1 Performance for Detecting Clinically Significant Prostate Cancer in Men in the PSA Gray Zone: A Retrospective Study

Qianyue Li, Yawei Zhao, Lei Tang, Junyao Zheng, Lin Li

Cancer Management and Research · 2026-11 · Volume 18 · 1-16

DOI: 10.2147/cmar.s625340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Management and Research, 2026-11. Verfasst von Qianyue Li und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate prostate volume (PV) alongside PI-RADS v2.1 for predicting prostate cancer (PCa) and clinically significant prostate cancer (csPCa), and to explore whether PV was associated with PI-RADS performance in men in the PSA gray zone (4– 10 ng/mL).

Methods

This retrospective study included 97 men who underwent pre-biopsy multiparametric MRI and pathological evaluation. PI-RADS performance was assessed overall and across PV strata. Two models were evaluated: Model A (PI-RADS, PV, age, and free-to-total PSA ratio) and Model B (PI-RADS, PSA density, age, and free-to-total PSA ratio). ROC analysis, DeLong tests, Firth penalized logistic regression incorporating a PI-RADS × PV interaction term, and bootstrap-corrected calibration were performed.

Results

PCa and csPCa were identified in 26 (26.8%) and 23 (23.7%) patients, respectively. For csPCa, PI-RADS ≥ 4 yielded a sensitivity of 73.9% (95% CI, 51.6– 89.8%) and specificity of 77.0% (95% CI, 65.8– 86.0%); PI-RADS ≥ 5 increased specificity to 89.2% (95% CI, 79.8– 95.2%) but reduced sensitivity to 47.8% (95% CI, 26.8– 69.4%). PCa and csPCa detection rates decreased across increasing PV categories (P for trend = 0.017 and 0.014, respectively), although the subgroup estimates were imprecise. Compared with PI-RADS alone, Model A showed higher discrimination for PCa (AUC, 0.809 vs 0.721; P = 0.021) and csPCa (AUC, 0.853 vs 0.770; P = 0.015). Model B yielded AUCs of 0.805 and 0.843, respectively, but its improvements over PI-RADS alone were borderline (P = 0.050 and 0.051). The PI-RADS × PV interaction was associated with csPCa (OR, 1.025; 95% CI, 1.002– 1.055). Bootstrap-corrected mean absolute errors were 0.037 for PCa and 0.039 for csPCa.

Conclusion

A model incorporating PV, age, and free-to-total PSA ratio alongside PI-RADS showed greater discrimination than PI-RADS alone in this cohort. The exploratory interaction suggests that the association between PI-RADS and csPCa may vary according to PV. External validation is required before clinical implementation. Keywords: prostate cancer, clinically significant prostate cancer, PI-RADS v2.1, prostate volume, PSA density, PSA gray zone

Zitieren

APA

Li, Q., Zhao, Y., Tang, L., Zheng, J., & Li, L. (2026). Association Between Prostate Volume and PI-RADS v2.1 Performance for Detecting Clinically Significant Prostate Cancer in Men in the PSA Gray Zone: A Retrospective Study. Cancer Management and Research, Volume 18, 1-16. https://doi.org/10.2147/cmar.s625340

Vancouver

Li Q, Zhao Y, Tang L, Zheng J, Li L. Association Between Prostate Volume and PI-RADS v2.1 Performance for Detecting Clinically Significant Prostate Cancer in Men in the PSA Gray Zone: A Retrospective Study. Cancer Management and Research. 2026;Volume 18:1-16. doi:10.2147/cmar.s625340

BibTeX
@article{Li2026,
  author = {Li, Qianyue and Zhao, Yawei and Tang, Lei and Zheng, Junyao and Li, Lin},
  title = {Association Between Prostate Volume and PI-RADS v2.1 Performance for Detecting Clinically Significant Prostate Cancer in Men in the PSA Gray Zone: A Retrospective Study},
  journal = {Cancer Management and Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--16},
  doi = {10.2147/cmar.s625340}
}
Kostenlos starten →